A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States

Figures & data

Figure 1. Invasive Pneumococcal Disease (IPD) Rates for Black and White US Persons (All Ages) Over Time, Active Bacterial Core Surveillance, 1997–2013.

Figure 2. Percentage of US children who Received ≥4 Doses of PCV by Age 19–35 Months, National Immunization Survey, 2005–2013.CDC/NCHS and National Center for Immunization and Respiratory Diseases, National Immunization Survey. Available from: http://www.cdc.gov/vaccines/stats-surv/imz-coverage.htm#nis and http://www.cdc.gov/nchs/nis.htm. See Appendix I, National Immunization Survey (NIS). Table 78.CDC. National, State, and Selected Local Area Vaccination Coverage among Children Aged 19–35 Months — United States, 2013. MMWR. Weekly / Vol. 63 / No. 34. August 29, 2014.

Figure 3. Percentage of US Children who Received ≥1, ≥2, and ≥3 Doses of PCV by Age 3, 5, and 7 Months, respectively, National Immunization Survey, 2002–2013CDC/NCHS and National Center for Immunization and Respiratory Diseases, National Immunization Survey, Coverage Level by Milestones. Available from: http://www.cdc.gov/vaccines/imz-managers/coverage/nis/child/index.html.

Table 1. Percent of US Children aged 19–35 months who received ≥4 doses of PCV by federal poverty level and racial group, 2013 National Immunization Survey

Racial Group
Federal Poverty Level (FPL)	White Children	Black Children	All Races
≥FPL	87.5%	79.8%	86.1%
<FPL	71.7%	71.8%	74.5%

Federal poverty level (FPL) depends on the number of individuals in a family or household. In 2014, for a one-person household, the FPL was $11,670 for the 48 Contiguous States and the District of Columbia (FPL is slightly higher in Alaska and Hawaii). For each additional family/household member, FPL increases by $4,060 (e.g., FPL is $23,850 for a 4-person household).